EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Four-week inhibition of the renin–angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks

Sean G Byars, Priscilla R Prestes iD, Varaporn Suphapimol, Fumihiko Takeuchi iD, Nathan De Vries, Michelle C Maier iD, Mariana Melo, David Balding, Nilesh Samani, Andrew M Allen, Norihiro Kato, Jennifer L Wilkinson-Berka und 2 weitere

Cardiovascular Research · 2024

DOI: 10.1093/cvr/cvae053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Sean G Byars und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Angiotensin II Type 1 Receptor Blockers, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Disease Models, Animal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council of Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Prevention of human hypertension is an important challenge and has been achieved in experimental models. Brief treatment with renin–angiotensin system (RAS) inhibitors permanently reduces the genetic hypertension of the spontaneously hypertensive rat (SHR). The kidney is involved in this fascinating phenomenon, but relevant changes in gene expression are unknown. Methods and results In SHR, we studied the effect of treatment between 10 and 14 weeks of age with the angiotensin receptor blocker, losartan, or the angiotensin-converting enzyme inhibitor, perindopril [with controls for non-specific effects of lowering blood pressure (BP)], on differential RNA expression, DNA methylation, and renin immunolabelling in the kidney at 20 weeks of age. RNA sequencing revealed a six-fold increase in renin gene (Ren) expression during losartan treatment (P < 0.0001). Six weeks after losartan, arterial pressure remained lower (P = 0.006), yet kidney Ren showed reduced expression by 23% after losartan (P = 0.03) and by 43% after perindopril (P = 1.4 × 10−6) associated with increased DNA methylation (P = 0.04). Immunolabelling confirmed reduced cortical renin after earlier RAS blockade (P = 0.002). RNA sequencing identified differential expression of mRNAs, miRNAs, and lncRNAs with evidence of networking and co-regulation. These included 13 candidate genes (Grhl1, Ammecr1l, Hs6st1, Nfil3, Fam221a, Lmo4, Adamts1, Cish, Hif3a, Bcl6, Rad54l2, Adap1, Dok4), the miRNA miR-145-3p, and the lncRNA AC115371. Gene ontogeny analyses revealed that these networks were enriched with genes relevant to BP, RAS, and the kidneys.

Conclusion

Early RAS inhibition in SHR resets genetic pathways and networks resulting in a legacy of reduced Ren expression and BP persisting for a minimum of 6 weeks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsDisease Models, AnimalDNA MethylationGene Regulatory NetworksHypertensionKidneyLosartanPerindoprilRats, Inbred SHRReninRenin-Angiotensin SystemAnimalsRatsArterial PressureBlood PressureEpigenesis, GeneticGene Expression RegulationTime FactorsTranscriptome

Stichwörter der Autor:innen

HypertensionPreventionReninSHR

Substanzen

Angiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsLosartanPerindoprilRenin

Autor:innen und Institutionen

  • The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.
  • Health Innovation and Transformation Centre, Federation University, Ballarat, Victoria, Australia.
  • Department of Anatomy & Physiology, School of Biomedical Sciences, University of Melbourne, Parkville, Victoria 3010, Australia.
  • Department of Gene Diagnostics and Therapeutics, National Center for Global Health and Medicine, Tokyo, Japan.
  • Melbourne Integrative Genomic and School of Mathematics & Statistics, University of Melbourne, Victoria, Australia.
  • Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.

ORCID-Profile: Priscilla R Prestes, Fumihiko Takeuchi, Michelle C Maier, Stephen B Harrap

Förderung

  • National Health and Medical Research Council of Australia

Zitieren

APA

Byars, S. G., Prestes, P. R., Suphapimol, V., Takeuchi, F., De Vries, N., Maier, M. C., Melo, M., Balding, D., Samani, N., Allen, A. M., Kato, N., Wilkinson-Berka, J. L., Charchar, F., & Harrap, S. B. (2024). Four-week inhibition of the renin–angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae053

Vancouver

Byars SG, Prestes PR, Suphapimol V, Takeuchi F, De Vries N, Maier MC, et al. Four-week inhibition of the renin–angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae053

BibTeX
@article{Byars2024,
  author = {Byars, Sean G and Prestes, Priscilla R and Suphapimol, Varaporn and Takeuchi, Fumihiko and De Vries, Nathan and Maier, Michelle C and Melo, Mariana and Balding, David and Samani, Nilesh and Allen, Andrew M and Kato, Norihiro and Wilkinson-Berka, Jennifer L and Charchar, Fadi and Harrap, Stephen B},
  title = {Four-week inhibition of the renin–angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks},
  journal = {Cardiovascular Research},
  year = {2024},
  doi = {10.1093/cvr/cvae053}
}
Kostenlos starten →